LATASHA WILLIAMS-PRINCE: Open Payments
NPI 1932633674 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,766 in 140 payments from 27 companies in 2025. Trend: 2023 $4,582 · 2024 $3,821 · 2025 $3,766
Food & beverage: $3,632Education: $134
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 20 | $634 |
| GlaxoSmithKline, LLC. | 18 | $516 |
| Merck Sharp & Dohme LLC | 10 | $328 |
| Verona Pharma, Inc. | 12 | $259 |
| GENZYME CORPORATION | 11 | $226 |
| Amgen Inc. | 9 | $163 |
| Regeneron Healthcare Solutions, Inc. | 5 | $162 |
| Grifols USA, LLC | 6 | $151 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $125 |
| Axsome Therapeutics, Inc. | 5 | $125 |
Products named: DUPIXENT, TEZSPIRE, NUCALA, WINREVAIR, Ohtuvayre, FASENRA, Prolastin-C Liquid, Adempas.
Industry payments across GA — which companies pay providers there.
